Draft legislation would overhaul federal IT procurement process

Laura Pedulli | | Health Exec | Policy & Regulations

Reps. Anna Eshoo (D-Calif.) and Gerry Connolly (D-Va.) have introduced draft legislation to create a new office in the White House to review and guide major IT projects while working to allow more small businesses to bid for federal contracts, reports The Hill.

The bill, “The Reforming Federal Procurement of Information Technology Act,” also would make permanent the three-year old position of U.S. Chief Technology Officer and give that person authority to hire employees outside the standard government pay schedule to allow for competitive hiring.

Noting that government IT projects often come in over budget and behind schedule, Eshoo said that the current $80 billion IT budget “is an absolutely unacceptable waste of taxpayer dollars.” She said that the bill ultimately “gives all American innovators a fair shake at competing for valuable federal IT contracts by lowering the burden of entry,” according to the article.

 

Laura Pedulli

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.